Trade CALC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
CalciMedica, Inc. (CALC) is trading at US$1.98, down 6.60% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$17.61M. Over the past 52 weeks, CALC has traded between US$1.91 and US$36.00. On Syfe you can trade CALC with $0 commission and add it to your watchlist.
| Previous close | US$2.12 |
|---|---|
| Market cap | US$17.61M |
| 52-week range | US$1.91 – US$36.00 |
| Volume | 23.15K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CalciMedica, Inc.
CalciMedica, Inc. is a clinical-stage biopharmaceutical company, which engages in developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Year: 2020
CalciMedica Reaches FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis
Jul 29, 2:08 PM · MT Newswires
CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review
Jun 24, 11:47 AM · MT Newswires
CalciMedica, Inc. (CALC) stock is trading at US$1.98, -6.60% from the previous close of US$2.12.
The market cap for CalciMedica, Inc. (CALC) stock is approximately US$17.61M.
The 52-week high for CalciMedica, Inc. (CALC) stock is US$36.00.
The 52-week low for CalciMedica, Inc. (CALC) stock is US$1.91.
CalciMedica, Inc. (CALC) does not currently pay a dividend.
Stay on top of CALC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
